- Home
- ALTG vs MIST Comparison
ALTG vs MIST Comparison
Compare ALTG & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALTG | MIST |
|---|---|---|
| Founded | 1984 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.0M | 176.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ALTG | MIST |
|---|---|---|
| Price | $6.55 | $1.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $11.33 | $8.50 |
| AVG Volume (30 Days) | 238.9K | ★ 3.4M |
| Earning Date | 03-04-2026 | 03-12-2026 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,824,900,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.40 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.54 | $0.63 |
| 52 Week High | $8.99 | $3.06 |
Technical Indicators
Market Signals| Indicator | ALTG | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 68.73 | 40.95 |
| Support Level | $6.22 | $1.97 |
| Resistance Level | $6.54 | $2.06 |
| Average True Range (ATR) | 0.32 | 0.12 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 94.79 | 18.75 |
Price Performance
Historical ComparisonAbout ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).